PDT Partners, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,180,000
+5.4%
65,991
+43.8%
0.08%
+14.9%
Q2 2021$1,120,000
+162.3%
45,892
+184.7%
0.07%
+138.7%
Q1 2021$427,000
+145.4%
16,120
-29.6%
0.03%
+158.3%
Q4 2020$174,000
-29.8%
22,912
-53.7%
0.01%
-25.0%
Q3 2020$248,000
-30.5%
49,500
-17.1%
0.02%
-33.3%
Q2 2020$357,00059,7420.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders